CRIS Current Research Information System

ULIASSI, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.050
NA - Nord America 2.945
EU - Europa 2.681
SA - Sud America 241
AF - Africa 206
Continente sconosciuto - Info sul continente non disponibili 182
OC - Oceania 5
Totale 9.310
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.860
IT - Italia 1.151
CN - Cina 792
SG - Singapore 772
VN - Vietnam 566
GB - Regno Unito 283
HK - Hong Kong 281
DE - Germania 241
SE - Svezia 220
BR - Brasile 176
IN - India 174
FR - Francia 127
KR - Corea 123
RU - Federazione Russa 103
BD - Bangladesh 92
NL - Olanda 91
CI - Costa d'Avorio 78
ES - Italia 66
JP - Giappone 62
IE - Irlanda 55
FI - Finlandia 53
CA - Canada 45
ZA - Sudafrica 43
TG - Togo 41
HR - Croazia 33
CH - Svizzera 30
PL - Polonia 30
BG - Bulgaria 28
PK - Pakistan 27
AR - Argentina 26
PH - Filippine 25
ID - Indonesia 23
TR - Turchia 23
GR - Grecia 21
AT - Austria 19
EE - Estonia 19
MX - Messico 19
PT - Portogallo 19
UA - Ucraina 18
TH - Thailandia 17
TW - Taiwan 16
CL - Cile 15
BE - Belgio 14
SC - Seychelles 12
CZ - Repubblica Ceca 11
DK - Danimarca 11
SI - Slovenia 11
EC - Ecuador 10
NG - Nigeria 10
CO - Colombia 9
IQ - Iraq 9
IR - Iran 9
JM - Giamaica 7
MY - Malesia 6
UZ - Uzbekistan 6
EG - Egitto 5
JO - Giordania 5
NP - Nepal 5
RO - Romania 5
SA - Arabia Saudita 5
AU - Australia 4
MA - Marocco 4
NO - Norvegia 4
AL - Albania 3
CR - Costa Rica 3
KE - Kenya 3
LT - Lituania 3
MT - Malta 3
SV - El Salvador 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
HN - Honduras 2
HU - Ungheria 2
KZ - Kazakistan 2
PY - Paraguay 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
GP - Guadalupe 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MD - Moldavia 1
MG - Madagascar 1
MQ - Martinica 1
MW - Malawi 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 9.121
Salva come PNG Salva come JPEG
Città #
Singapore 549
Bologna 296
Ashburn 282
Hong Kong 257
Hefei 230
San Jose 229
Southend 210
Chandler 197
Fairfield 181
Ho Chi Minh City 151
Hanoi 141
Seoul 111
Milan 103
Woodbridge 103
Ann Arbor 101
Santa Clara 93
Los Angeles 92
Houston 91
Wilmington 91
Beijing 83
Abidjan 78
Cambridge 77
Dallas 76
Council Bluffs 68
Seattle 66
Boardman 57
Princeton 57
Dublin 55
Turin 51
New York 45
Lauterbourg 42
Lomé 41
Tokyo 41
Helsinki 38
Stockholm 34
São Paulo 31
Rome 29
Berlin 28
Florence 28
Bengaluru 27
Da Nang 26
Hyderabad 25
Frankfurt am Main 24
Sofia 24
Bremen 23
Portogruaro 23
Westminster 21
Cesena 20
Chicago 20
Buffalo 19
Haiphong 19
Redmond 19
Redondo Beach 19
Amsterdam 18
Munich 18
Bern 17
Guangzhou 17
Jinan 17
Madrid 17
Johannesburg 16
Nanjing 16
Padova 16
Redwood City 16
Barcelona 15
Naples 15
London 14
Modena 14
Atlanta 13
Dong Ket 13
Falls Church 13
Jakarta 13
Rimini 13
Shanghai 13
Athens 12
Brooklyn 12
Fremont 12
Montreal 12
Nuremberg 12
Ravenna 12
Lisbon 11
Ljubljana 11
Nanchang 11
Phoenix 11
Vadodara 11
Dearborn 10
Des Moines 10
Lahore 10
Lappeenranta 10
Saint Petersburg 10
San Diego 10
Forlì 9
Jiaxing 9
San Francisco 9
Taranto 9
Tianjin 9
Torrejón de Ardoz 9
Vienna 9
Belo Horizonte 8
Brussels 8
Cagliari 8
Totale 5.420
Salva come PNG Salva come JPEG
Nome #
A Focused Library of Psychotropic Analogues with Neuroprotective and Neuroregenerative Potential 440
PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease 346
Targeted Protein Degradation for Infectious Diseases: from Basic Biology to Drug Discovery 314
Fragment Merging, Growing, and Linking Identify New Trypanothione Reductase Inhibitors for Leishmaniasis 312
Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One 309
Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease 282
Integrating a quinone substructure into histone deacetylase inhibitors to cope with Alzheimer's disease and cancer 251
Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease 242
Sustainable production of pharmaceutical, nutraceutical and bioactive compounds from biomass and waste 242
Targeting Lewy body dementia with neflamapimod-rasagiline hybrids 240
Harnessing the 12 Green Chemistry Principles for Sustainable Antiparasitic Drugs: Toward the One Health Approach 237
Discovery of Sustainable Drugs for Neglected Tropical Diseases: Cashew Nut Shell Liquid (CNSL)-Based Hybrids Target Mitochondrial Function and ATP Production in Trypanosoma brucei 224
Click Chemistry and Targeted Degradation: A Winning Combination for Medicinal Chemists? 222
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform 220
Turning Donepezil into a Multi-Target-Directed Ligand through a Merging Strategy 220
Development of a Focused Library of Triazole-Linked Privileged-Structure-Based Conjugates Leading to the Discovery of Novel Phenotypic Hits against Protozoan Parasitic Infections 210
Multitarget Drug Design Strategy: Quinone–Tacrine Hybrids Designed To Block Amyloid-β Aggregation and To Exert Anticholinesterase and Antioxidant Effects 204
Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties 203
Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's Disease 201
Riluzole-Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis 199
Targeting Tau Protein with Proximity Inducing Modulators: A New Frontier to Combat Tauopathies 197
Cashew nut shell liquid (Cnsl) as a source of drugs for alzheimer’s disease 179
Medicinal Chemistry of Hybrids for Neurodegenerative Diseases 177
Medicinal Chemistry: A Key Driver in Achieving the Global Sustainable Development Goals 162
A perspective on multi-target drug discovery and design for complex diseases 161
Drug Discovery Strategies for the Generation of Multitarget Ligands against Neglected Tropical Diseases 155
Identification of a Quinone Derivative as a YAP/TEAD Activity Modulator from a Repurposing Library 151
Toward the Development of Dual-Targeted Glyceraldehyde-3-phosphate Dehydrogenase/Trypanothione Reductase Inhibitors againstTrypanosoma bruceiandTrypanosoma cruzi 150
Design, synthesis, pharmacological characterization of a fluorescent agonist of the P2Y14 receptor 144
Tackling Neuroinflammation in Cognitive Disorders with Single-targeted and Multi-targeted Histamine H3 Receptor Modulators 141
TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS 138
Molecular basis for covalent inhibition of glyceraldehyde-3-phosphate dehydrogenase by a 2-phenoxy-1,4-naphthoquinone small molecule 130
Two diseases, one approach: multitarget drug discovery in Alzheimer's and neglected tropical diseases 129
From Companion Diagnostics to Theranostics: A New Avenue for Alzheimer's Disease? 128
Overcoming the Challenges of Multi‐Target‐Directed Ligands for Alzheimer's Disease 126
The Use of Zidovudine Pharmacophore in Multi-Target-Directed Ligands for AIDS Therapy 126
Neuroregeneration versus neurodegeneration: Toward a paradigm shift in Alzheimer's disease drug discovery 122
TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS 121
Structure-Based Design of 3-(4-Aryl-1H-1,2,3-triazol-1-yl)-Biphenyl Derivatives as P2Y14 Receptor Antagonists 118
Medicinal Chemistry Strategies to Combat Neurodegenerative Diseases 109
Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease 109
Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activity 109
Triazole derivatives as P2Y14 receptor antagonists 107
null 98
null 93
null 93
null 89
Therapeutic strategies for identifying small molecules against prion diseases 88
New Therapeutic Modalities in Prion Diseases 85
Environmental impacts of drugs against parasitic vector-borne diseases and the need to integrate sustainability into their development and use 83
null 83
The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment 81
Polypharmacology approaches for brain disorders aimed to enhance brain permeability and circadian clock targeting 80
null 73
PROGETTAZIONE DI PACKAGING EDIBILE E SOSTENIBILE: SINERGIA TRA GIOVANI E RICERCA UNIVERSITARIA 57
Totale 9.310
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.793
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.793
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022589 0 20 29 33 74 49 28 38 37 31 143 107
2022/2023994 72 135 75 89 73 77 46 88 124 34 98 83
2023/2024602 33 51 44 47 52 67 51 23 41 71 77 45
2024/20251.644 128 156 131 129 189 100 123 95 79 115 126 273
2025/20263.764 322 470 342 307 322 187 468 136 631 213 259 107
2026/2027287 186 101 0 0 0 0 0 0 0 0 0 0
Totale 9.310